Erythromycin remains gold standard for treatment of pertussis in infants.
Osterholm
M T
MT
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004917:Erythromycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011707:Pyloric Stenosis / Q000139:chemically induced*; D018570:Risk Assessment; D016896:Treatment Outcome; D014917:Whooping Cough / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004917:Erythromycin